Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 284.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.70 | 52 Week High | $139.79 | |||
| Open | $284.70 | 52 Week Low | $82.07 | |||
| Day High | $284.70 | P/E | 662.09 | |||
| Day Low | $284.70 | EPS | $0.43 | |||
| Volume | 921 | |||||

